Company Overview and News

13
Nifty rises 55.90 pts to 4-month high post Trump-Kim meeting

2018-06-12 freepressjournal.in
Mumbai: NSE Nifty rose by 55.90 points to close at four-month high of 10,842.85 on sustained buying mainly in pharma, FMCG, PSU banks, energy and IT sectors amid positive sentiment from global equity markets.
ECQRY INDUSINDBK HINDUNILVR BHRQY 533278 500182 532454 505200 532187 500696 HEROMOTOCO HRTQY BHARTIARTL EICHERMOT CLNDY COALINDIA

2
Eicher Motors Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
505200 ECQRY EICHERMOT

2
‘We’re a bunch of storytellers running a motorcycle company’

2018-06-09 livemint
Rudratej Singh, president of motorcycle maker Royal Enfield, is bullish on the fastest-growing two-wheeler brand, which is propelling the growth of the middleweight motorcycle segment (250cc-750cc) in India and the world over. Cue, the nostalgia alert. The company’s nostalgia play with its classic range—Continental GT and the Pegasus Classic 500, which is inspired by Royal Enfield’s British World War II Flying Flea bikes—has gone a long way in promoting the brand value in more ways than one.
505200 ECQRY EICHERMOT

23
Banks drag Sensex 215 pts, Nifty below 10,700 ahead of RBI policy; Midcap continues to dip

2018-06-04 moneycontrol
The market started off the week on a strong note following positive global cues post better-than-expected US jobs report, but wiped out all its gains within few minutes from opening with the Sensex falling more than 200 points on Monday.
500325 RELIANCE 532978 BHRQY 505200 500470 RIGD HDFCBANK BHARTIARTL EICHERMOT RLNIY ECQRY HINDALCO KMBKY HNDNF 532454 BAJAJFINSV TTST TATASTEEL TATLY HDB 500180 KOTAKBANK 500247 500440

2
Eicher Motors Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
505200 ECQRY EICHERMOT

2
VE Commercial Vehicles sales up by 31% in May

2018-06-01 moneycontrol
VE Commercial Vehicles, a joint venture between Volvo Group and Eicher Motors, today reported 30.7 percent increase in sales in May this year to 5,977 units. It had sold 4,573 units in May 2017, VECV said in a statement.
505200 ECQRY EICHERMOT

52
Nifty ends below 10,700, all sectoral indices in the red except Auto; Sensex up 1% for week

2018-06-01 moneycontrol
Benchmark indices closed in the red after volatility on first day of June series Friday as all sectoral indices were in the red barring Auto that outperformed all post May sales data. Continuous correction in midcaps dampened investors sentiment, which led to profit booking after more than 400 points rally on the Sensex in previous session.
BAJAJ-AUTO 500325 RELIANCE 532978 532977 BHRQY 532215 505200 500470 532187 AXISBANK RIGD HDFCBANK HEROMOTOCO BJJQY 500570 BHARTIARTL TATAMOTORS EICHERMOT RLNIY 500034 ECQRY HINDALCO AXB INDUSINDBK KMBKY IBN AXBKY 500182 HNDNF 532454 AXBA ICICIBANK BAJAJFINSV BAJFINANCE TTST TATASTEEL TATLY HDB 532174 500180 KOTAKBANK HRTQY 500247 500440 TTM

26
Market Live: Sensex mildly lower; all sectoral indices in the red except Auto

2018-06-01 moneycontrol
Market Update: The market continued to be mildly under pressure amid consolidation, but European stocks are strong in trade after Italy agreed to form a government.
BAJAJ-AUTO 539150 513262 500325 GAYAPROJ RELIANCE TTQQY 530239 PNCINFRA 532977 SUVEN TATACHEM 531795 505200 532343 RIGD HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500770 RLNIY ASHOKLEY ECQRY TVSMOTOR IBN ATULAUTO 532767 532843 MRZUY AKLD 532500 500182 ICICIBANK FORTIS MARUTI 532174 HRTQY AKLS SSWL TTM

2
Eicher Motors Limited - Updates

2018-06-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
505200 ECQRY EICHERMOT

29
Market Live: Sensex mildly lower, Midcaps underperform; HDFC Bank drags, Eicher Motors dips 4%

2018-06-01 moneycontrol
Allahabad High Court on Power NPAs: Allahabad High Court has stayed the Reserve Bank of India’s February 12 circular on resolution on non-performing assets (NPAs) for the assets in the power sector.
BAJAJ-AUTO 539150 513262 GAYAPROJ TTQQY 530239 PNCINFRA 532977 SUVEN TATACHEM 531795 505200 533106 OIL HDFCBANK HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500770 ASHOKLEY ECQRY IBN ATULAUTO 532767 532843 MRZUY AKLD 532500 500182 ICICIBANK FORTIS HDB MARUTI 532174 500180 HRTQY AKLS SSWL TTM

23
Market Live: Nifty holds 10,700 amid consolidation; Bajaj Auto extends rally

2018-06-01 moneycontrol
Market Update: The market continued to be rangebound as investors digested better-than-expected Q4 GDP data, which shows India is the fastest growing economy, and shifted focus to global trade concerns, and the movement in crude oil prices & rupee.
BAJAJ-AUTO 539150 TTQQY 530239 PNCINFRA 532977 SUVEN TATACHEM 505200 533106 GRANULES OIL 532482 HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500770 ASHOKLEY ECQRY IBN 532843 MRZUY AKLD 532500 500182 ICICIBANK FORTIS MARUTI 532174 HRTQY AKLS TTM

2
Eicher Motors Limited - Updates

2018-06-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
505200 ECQRY EICHERMOT

6
Tata Motors shares underperform four-wheeler peers

2018-05-31 thehindubusinessline
Priya Kansara Tata Motors’ shares have underperformed its four-wheeler peers namely Maruti Suzuki and M&M over the last decade. While Tata Motors’ market capitalisation has grown around four times, those of Maruti and M&M grew 12 and 7 times, respectively as on May 30, according to data provided by Capitaline.
505200 ECQRY 500570 TATAMOTORS EICHERMOT TTM

Related Articles

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

STML: Stemline Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...

CUSIP: 006099819